News
EOCN
3.150
+3.96%
0.120
Weekly Report: what happened at EOCN last week (1019-1023)?
Weekly Report · 1d ago
Weekly Report: what happened at EOCN last week (1012-1016)?
Weekly Report · 10/19 09:12
Weekly Report: what happened at EOCN last week (1005-1009)?
Weekly Report · 10/12 09:12
12 Health Care Stocks Moving In Thursday's Pre-Market Session
Benzinga · 10/08 12:05
Weekly Report: what happened at EOCN last week (0928-1002)?
Weekly Report · 10/05 09:12
Weekly Report: what happened at EOCN last week (0921-0925)?
Weekly Report · 09/28 09:12
Weekly Report: what happened at EOCN last week (0914-0918)?
Weekly Report · 09/21 09:12
12 Health Care Stocks Moving In Monday's After-Market Session
Benzinga · 09/14 21:06
Weekly Report: what happened at EOCN last week (0907-0911)?
Weekly Report · 09/14 09:12
Analysts Offer Insights on Healthcare Companies: Eocene (EOCN) and Dyne Therapeutics (DYN)
TipRanks · 09/10 18:40
Galmed Pharma Rebrands To EoCene, Debuts EOCN Ticker As GI Expansion Accelerates; Stock Up
NASDAQ · 09/09 15:06
Galmed Rebrands as EoCene, Secures Nasdaq Compliance and Ends Yorkville Equity Line
TipRanks · 09/09 12:33
Galmed Pharmaceuticals Becomes EoCene, Unveiling New Ticker Symbol "EOCN" to Reflect its New Dawn Platform for GI Innovation
PR Newswire · 09/09 11:30
Galmed Pharmaceuticals Regains Nasdaq Bid-Price Compliance, Avoids Delisting Risk
TipRanks · 09/08 10:31
Weekly Report: what happened at GLMD last week (0831-0904)?
Weekly Report · 09/07 09:11
6 Biotech Stocks In Focus: Modular Medical, Galmed, Pro-Dex, Connect Biopharma & More
NASDAQ · 09/04 02:47
Galmed Pharmaceuticals Shareholders Approve All Proposals at September 3 AGM
TipRanks · 09/03 23:30
Galmed Pharmaceuticals: Q2 Earnings Snapshot
Barchart · 09/03 10:52
Galmed Pharmaceuticals Posts Higher R&D Spend and Shrinking Cash in Q2 2026
TipRanks · 09/02 21:18
Galmed Pharmaceuticals Adjourns Shareholder Meeting for Lack of Quorum
TipRanks · 09/02 20:27
More
Webull provides a variety of real-time EOCN stock news. You can receive the latest news about Eocene Ltd through multiple platforms. This information may help you make smarter investment decisions.
About EOCN
EoCene Ltd., formerly Galmed Pharmaceuticals Ltd., is an Israel-based healthcare technology and biopharmaceutical company engaged in the development of therapeutic products, medical devices, and healthcare technologies. The Company focuses on gastrointestinal diseases, gastrointestinal oncology, and related medical conditions through a portfolio of pharmaceutical and medical device programs. Its activities include research, development, clinical evaluation, and commercialization of therapeutic candidates and medical technologies. The Company’s portfolio includes Aramchol, a therapeutic candidate for liver and oncology-related indications, and medical device technologies developed through its subsidiary Colospan Ltd. for gastrointestinal and colorectal applications. EoCene Ltd. conducts its operations through biopharmaceutical, medical device, and healthcare technology activities.